United States. Food and Drug Administration

245 additional books about United States Food and Drug Administration in the extended shelves:

Public hazards from unsatisfactory medical diagnostic products, Food and Drug Administration, Department of Health, Education, and Welfare : report to the Congress (U.S. General Accounting Office, 1975), by United States General Accounting Office (page images at HathiTrust)
Assessment of the Food and Drug Administration's handling of reports on adverse reactions from the use of drugs (The Office, 1974), by United States General Accounting Office (page images at HathiTrust)
Final report (Dept. of Health, Education, and Welfare, 1977), by Education United States. Department of Health (page images at HathiTrust)
A legislative history of the Federal Food, Drug, and Cosmetic Act and its amendments. (Dept. of Health, Education and Welfare, Public Health Service, Food and Drug Administration, 1979), by United States and United States Food and Drug Administration (page images at HathiTrust)
Assessment of the Commissioner's report of October 1975 (The Department, 1976), by Education United States. Department of Health (page images at HathiTrust)
FDA 1978 consumer food labeling survey (U.S. Dept. of Health, Education, and Welfare, Food and Drug Administration, Bureau of Foods, Division of Consumer Studies, 1979), by James T. Heimbach and Raymond C. Stokes (page images at HathiTrust)
Federal pesticide registration program: is it protecting the public and the environment adequately from pesticide hazards?, Environmental Protection Agency, Food and Drug Administration (HEW) : report to the Congress (Washington, DC : U.S. General Accounting Office, 1975., 1975), by United States General Accounting Office (page images at HathiTrust)
Excluding substandard canned pineapple from the United States : Food and Drug Administration, Department of Health, Education and Welfare (The Office, 1975), by United States General Accounting Office (page images at HathiTrust)
The Commissioner's report of investigation of charges from joint hearings, Subcommittee on Health, Labor and Public Welfare Committee, Subcommittee on Administrative Practice and Procedure, Judiciary Committee, United States Senate, August 15-16, 1974. ([Food and Drug Administration?], 1975), by United States Food and Drug Administration and Alexander M. Schmidt (page images at HathiTrust)
The Food, drug, and insecticide administration (The Johns Hopkins press, 1928), by Gustavus Adolphus Weber (page images at HathiTrust)
Problems in obtaining and enforcing compliance with good manufacturing practices for drugs, Food and Drug Administration, Department of Health, Education and Welfare ([Washington], 1973), by United States General Accounting Office (page images at HathiTrust)
Protecting the consumer from potentially harmful shellfish (clams, mussels, and oysters): Food and Drug Administration, Department of Health, Education, and Welfare ([Washington, 1973), by United States General Accounting Office and United States Congress (page images at HathiTrust)
IRB information sheet. (Dept. of Health & Human Services, Public Health Service, Food and Drug Administration, 1984), by United States Food and Drug Administration (page images at HathiTrust)
Medical devices : FDA's implementation of the medical device reporting regulation : report to the Chairman, Subcommittee on Health and the Environment, Committee on Energy and Commerce, House of Representatives (The Office, 1989), by United States General Accounting Office and United States. Congress. Committee on Energy and Commerce. Subcommittee on Health and the Environment (page images at HathiTrust)
Final report of the Advisory Committee on the Food and Drug Administration. (The Committee, 1991), by United States. Dept. of Health and Human Services. Advisory Committee on the Food and Drug Administration (page images at HathiTrust)
A plan for action : phase II. (U.S. Dept. of Health and Human Services, Public Health Service, Food and Drug Administration, 1987), by United States Food and Drug Administration (page images at HathiTrust)
Guideline for the format and content of the nonclinical pharmacology/toxicology section of an application. (Center for Drugs and Biologics, Food and Drug Administration, Dept. of Health and Human Services, 1987), by Center for Drugs and Biologics (U.S.) (page images at HathiTrust)
"Aplan for action". (Food and Drug Administration, U.S. Public Health Service, Dept. of Health and Human Services, 1985), by United States Food and Drug Administration (page images at HathiTrust)
Food and Drug Administration advisory committees (National Academy Press :, 1992), by Richard A. Merrill, Laurence E. Earley, Richard A. Rettig, United States Food and Drug Administration, Institute of Medicine (U.S.). Division of Health Sciences Policy, and Institute of Medicine (U.S.). Committee to Study the Use of Advisory Committees by the Food and Drug Administration (page images at HathiTrust)
Field laboratory profile, 1985 (The Division, 1985), by United States. Food and Drug Administration. Office of Regional Operations. Division of Field Science (page images at HathiTrust)
Drug regulation reform--oversight hearing before the Subcommittee on Health and the Environment of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-sixth Congress, second session .... (U.S. G.P.O., 1980), by United States. Congress. House. Committee on Interstate and Foreign Commerce. Subcommittee on Health and the Environment (page images at HathiTrust)
Soft contact lens solutions oversight of FDA : hearing before the Subcommittee on Oversight and Investigations of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-sixth Congress, second session, July 1, 1980. (U.S. G.P.O., 1980), by United States. Congress. House. Committee on Interstate and Foreign Commerce. Subcommittee on Oversight and Investigations (page images at HathiTrust)
FDA regulation of soft contact lens hearing before the Subcommittee on Oversight and Investigations of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-sixth Congress, second session, December 12, 1980. (U.S. G.P.O., 1981), by United States. Congress. House. Committee on Interstate and Foreign Commerce. Subcommittee on Oversight and Investigations (page images at HathiTrust)
FDA oversight medical devices : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, Ninety-seventh Congress, second session, July 16, 1982. (U.S. G.P.O., 1982), by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations (page images at HathiTrust)
FDA's regulation of Zomax hearings before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-eighth Congress, first session, April 26 and 27, 1983. (U.S. G.P.O., 1983), by United States. Congress. House. Committee on Government Operations. Intergovernmental Relations and Human Resources Subcommittee (page images at HathiTrust)
Drug lag hearing before the Subcommittee on Natural Resources, Agriculture Research, and Environment of the Committee on Science and Technology, U.S. House of Representatives, Ninety-seventh Congress, first session, September 16, 1981. (U.S. G.P.O., 1983), by Agriculture Research United States. Congress. House. Committee on Science and Technology. Subcommittee on Natural Resources (page images at HathiTrust)
FDA proposals to ease restrictions on the use and sale of experimental drugs hearing before a subcommittee of the Committee on Government Operations, House of Representatives, One hundredth Congress, first session, April 29, 1987. (U.S. G.P.O., 1987), by United States. Congress. House. Committee on Government Operations. Human Resources and Intergovernmental Relations Subcommittee (page images at HathiTrust)
FDA's generic drug approval process : hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred First Congress, first session part 1 (U.S. G.P.O. :, 1989), by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations (page images at HathiTrust)
Preclinical and clinical testing by the pharmaceutical industry, 1976 joint hearings before the Subcommittee on Health of the Committee on Labor and Public Welfare and the Subcommittee on Administrative Practice and Procedure of the Committee on the Judiciary, United States Senate, Ninety-fourth Congress, second session, on examination of the process of drug testing and FDA's role in the regulation and conditions under which such testing is carried out ... (U.S. Govt. Print. Off., 1976), by United States. Congress. Senate. Committee on Labor and Public Welfare. Subcommittee on Health and United States. Congress. Senate. Committee on the Judiciary. Subcommittee on Administrative Practice and Procedure (page images at HathiTrust)
FDA's regulation of the drug "triazure" : hearing before a Subcommittee of the Committee on Government Operations, House of Representatives, Ninety-fourth Congress, second session. October 27, 1976. (U.S. Govt. Print. Off. :, 1976), by United States. Congress. House. Committee on Government Operations. Intergovernmental Relations and Human Resources Subcommittee (page images at HathiTrust)
Preclinical and clinical testing by the pharmaceutical industry, 1977 hearing before the Subcommittee on Health and Scientific Research of the Committee on Human Resources, United States Senate, Ninety-fifth Congress, first session ... (U.S. Govt. Print. Off., 1977), by United State Senate Subcommittee on Health and Scientific Research, United States. Congress. Senate. Committee on the Judiciary. Subcommittee on Administrative Practice and Procedure, and United States. Congress. Senate. Committee on Labor and Public Welfare. Subcommittee on Health (page images at HathiTrust)
Banning of the drug Laetrile from interstate commerce by FDA hearing before the Subcommittee on Health and Scientific Research of the Committee on Human Resources, United States Senate, Ninety-fifth Congress, first session ... July 12, 1977. (U.S. Govt. Print. Off., 1977), by United State Senate Subcommittee on Health and Scientific Research (page images at HathiTrust)
Food and Drug Administration practice and procedure, 1976 joint hearing before the Subcommittee on Health of the Committee on Labor and Public Welfare and the Subcommittee on Administrative Practice and Procedure of the Committee on the Judiciary, United States Senate, Ninety-fourth Congress, second session ... July 20, 1976. (U.S. Govt. Print. Off., 1976), by United States. Congress. Senate. Committee on Labor and Public Welfare. Subcommittee on Health and United States. Congress. Senate. Committee on the Judiciary. Subcommittee on Administrative Practice and Procedure (page images at HathiTrust)
Food and Drug Administration's food labeling regulation its effect on small business : hearings before the Subcommittee on Special Small Business Problems of the Committee on Small Business, House of Representatives, Ninety-fifth Congress, second session ... July 13, August 3, 1977, and March 15, 1978. (U.S. Govt. Print. Off., 1978), by United States. Congress. House. Committee on Small Business. Subcommittee on Special Small Business Problems (page images at HathiTrust)
Quality of scientific evidence in FDA regulatory decisions : the adoption of an antismoking warning in oral contraceptive pill labeling : hearing before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-fifth Congress, second session, October 4, 1978. (U.S. Govt. Print. Off. :, 1978), by United States. Congress. House. Committee on Government Operations. Intergovernmental Relations and Human Resources Subcommittee (page images at HathiTrust)
"Man-in-the-plant", FDA's failure to regulate deceptive drug labeling hearings before the Subcommittee on Oversight and Investigations of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-fifth Congress, second session, September 8 and 12, 1978. (U.S. Govt. Print. Off., 1978), by United States. Congress. House. Committee on Interstate and Foreign Commerce. Subcommittee on Oversight and Investigations (page images at HathiTrust)
Regulation of over-the-counter drugs hearing before the Subcommittee on Oversight and Investigations of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-sixth Congress, first session, June 22, 1979. (U.S. Govt. Print. Off., 1979), by United States. Congress. House. Committee on Interstate and Foreign Commerce. Subcommittee on Oversight and Investigations (page images at HathiTrust)
"Man-in-the-plant" revisited, a deceptive drug labeling practice continues hearing before the Subcommittee on Oversight and Investigations of the Committee on Interstate and Foreign Committee, House of Representatives, Ninety-sixth Congress, second session, March 6, 1980. (U.S. Govt. Print. Off., 1980), by United States. Congress. House. Committee on Interstate and Foreign Commerce. Subcommittee on Oversight and Investigations (page images at HathiTrust)
Infant formula : our children need better protection : report together with dissenting views (U.S. Govt. Print. Off. : for sale by the Supt. of Docs., U.S. Govt. Print. Off., 1980), by United States. Congress. House. Committee on Interstate and Foreign Commerce. Subcommittee on Oversight and Investigations (page images at HathiTrust)
The Food and Drug Administration's process for approving new drugs oversight : hearings before the Subcommittee on Science, Research, and Technology of the Committee on Science and Technology, U.S. House of Representatives, Ninety-sixth Congress, first session, June 19, 21, July 11, 1979. (U.S. Govt. Print. Off., 1979), by Research United States. Congress. House. Committee on Science and Technology. Subcommittee on Science (page images at HathiTrust)
The Food and Drug Administration's process for approving new drugs : report (U.S. G.P.O. :, 1980), by Research United States. Congress. House. Committee on Science and Technology. Subcommittee on Science (page images at HathiTrust)
Preclinical and clinical testing by the pharmaceutical industry, 1979 hearing before the Subcommittee on Health and Scientific Research of the Committee on Labor and Human Resources, United States Senate, Ninety-sixth Congress, first session ... October 11, 1979. (U.S. Govt. Print. Off., 1979), by United States. Congress. Senate. Committee on Labor and Human Resources. Subcommittee on Health and Scientific Research (page images at HathiTrust)
Reinventing drug & medical device regulations (National Performance Review, 1995), by Bill Clinton, Al Gore, and National Performance Review (U.S.) (page images at HathiTrust)
New drug development in the United States (Dept. of Health & Human Services, Public Health Service, Food and Drug Administration, 1995), by United States Food and Drug Administration (page images at HathiTrust)
Use of advisory committees by the Food and Drug Administration hearings before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-third Congress, second session ... . (U.S. Govt. Print. Off., 1975), by United States. Congress. House. Committee on Government Operations. Intergovernmental Relations Subcommittee and United States. Congress. House. Committee on Government Operations. Intergovernmental Relations and Human Resources Subcommittee (page images at HathiTrust)
Oversight of FTC's shared responsibilities : hearing before the Subcommittee on Transportation and Hazardous Materials of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, first session, concerning advertising and labeling issues with the Bureau of Alcohol, Tobacco, and Firearms, the Environmental Protection Agency, and the Food and Drug Administration, November 21, 1991. (U.S. G.P.O. :, 1992), by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Transportation and Hazardous Materials (page images at HathiTrust)
FDA and the medical device industry : hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, second session, March 25 and June 3, 1992. (U.S. G.P.O. :, 1992), by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations (page images at HathiTrust)
FDA's drug and device review process : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, second session, February 6, 1992. (U.S. G.P.O. :, 1992), by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations (page images at HathiTrust)
User fees for prescription drugs : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, second session, August 10, 1992. (U.S. G.P.O. :, 1992), by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment (page images at HathiTrust)
Report of the Commission on Dietary Supplement Labels (The Commission, 1997), by United States. Commission on Dietary Supplement Labels (page images at HathiTrust)
FDA plan for statutory compliance (FDA, 1998), by United States Food and Drug Administration (page images at HathiTrust)
User fees for prescription drugs : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, second session, August 10, 1992. (U.S. G.P.O. :, 1992), by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment (page images at HathiTrust)
Food safety : federal efforts to ensure the safety of imported foods are inconsistent and unreliable, report to the Chairman, Permanent Subcommittee on Investigations, Committee on Governmental Affairs, U.S. Senate (The Office, 1998), by United States General Accounting Office and United States. Congress. Senate. Committee on Governmental Affairs. Permanent Subcommittee on Investigations (page images at HathiTrust)
Problems with FDA monitoring for animal drug residues : is our milk safe? : hearing before the Human Resources and Intergovernmental Relations Subcommittee of the Committee on Government Operations, House of Representatives, One Hundred Second Congress, second session, August 5, 1992. (U.S. G.P.O. :, 1993), by United States. Congress. House. Committee on Government Operations. Human Resources and Intergovernmental Relations Subcommittee (page images at HathiTrust)
Medical devices : hearing before the Committee on Labor and Human Resources, United States Senate, One Hundred First Congress, second session : on examing proposed legislation ... July 25, 1990. (U.S. G.P.O. :, 1990), by United States Senate Committee on Labor and Human Resources (page images at HathiTrust)
FDA user fees : current measures not sufficient for evaluating effect on public health : report to the Chairman, Human Resources and Intergovernmental Relations Subcommittee, Committee on Government Operations, House of Representatives (The Office, 1994), by United States General Accounting Office and United States. Congress. House. Committee on Government Operations. Human Resources and Intergovernmental Relations Subcommittee (page images at HathiTrust)
Review time has decreased in recent years (The Office ;, 1995), by United States General Accounting Office (page images at HathiTrust)
Food safety and quality : FDA surveys not adequate to demonstrate safety of milk supply : report to the chairman, Human Resources and Intergovernmental Relations Subcommittee, Committee on Government Operations, House of Representatives (The Office, 1990), by United States General Accounting Office (page images at HathiTrust)
Medical device user fees : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred Third Congress, second session, on H.R. 4728, a bill to amend the Federal Food, Drug, and Cosmetic Act to authorize a device application fee, and for other purposes, July 14, 1994. (U.S. G.P.O. :, 1994), by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment (page images at HathiTrust)
Revitalizing new product development from clinical trials through FDA review : hearing of the Committee on Labor and Human Resources, United States Senate, One Hundred Fourth Congress, second session, on S. 1477 ... February 21, 1996. (U.S. G.P.O. :, 1996), by United States Senate Committee on Labor and Human Resources (page images at HathiTrust)
FDA's regulation of Carcinogenic additives : hearing before a subcommittee of the Committee on Government Operations, House of Representatives, One hundredth Congress, first session, June 24, 1987. (U.S. G.P.O. :, 1987), by United States. Congress. House. Committee on Government Operations. Human Resources and Intergovernmental Relations Subcommittee (page images at HathiTrust)
FDA's continuing failure to regulate health claims for foods : hearings before the Human Resources and Intergovernmental Relations Subcommittee of the Committee on Government Operations, House of Representatives, One Hundred First Congress, first session, October 31 and November 9, 1989. (U.S. G.P.O. :, 1990), by United States. Congress. House. Committee on Government Operations. Human Resources and Intergovernmental Relations Subcommittee (page images at HathiTrust)
FDA's regulation of the dietary supplement L-tryptophan : hearing before the Human Resources and Intergovernmental Relations Subcommittee of the Committee on Government Operations, House of Representatives, One Hundred Second Congress, first session, July 18, 1991. (U.S. G.P.O. :, 1992), by United States. Congress. House. Committee on Government Operations. Human Resources and Intergovernmental Relations Subcommittee (page images at HathiTrust)
FDA and the medical device industry : hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, second session, March 25 and June 3, 1992. (U.S. G.P.O. :, 1992), by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations (page images at HathiTrust)
Advisory Committee on the Food and Drug Administration : final report : hearing of the Committee on Labor and Human Resources, United States Senate, One Hundred Second Congress, first session, on reviewing the Advisory Committee on the Food and Drug Administration report on the current state of FDA, and its recommendations to strengthen FDA, May 15, 1991. (U.S. G.P.O. :, 1992), by United States Senate Committee on Labor and Human Resources (page images at HathiTrust)
Food and Drug Administration oversight : hearings before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives. (U.S. G.P.O. :, 1991), by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment (page images at HathiTrust)
FDA and USDA need a coordinated assessment of food label accuracy, report to the Chairman (The Office ;, 1994), by United States General Accounting Office and Nutrition United States. Congress. Senate. Committee on Agriculture (page images at HathiTrust)
Food safety and quality : Who does what in the federal government (The Office, 1990), by United States General Accounting Office (page images at HathiTrust)
Food, drug, cosmetic, and device enforcement amendments : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, first session, on H.R. 2597, a bill to amend the Federal Food, Drug, and Administration, July 17, 1991. (U.S. G.P.O. :, 1991), by United States. Congress. House. Committee on House and Commerce. Subcommittee on Health and the Environment (page images at HathiTrust)
Food, Drug, Cosmetic, and Device Enforcement Authorities Act : hearing of the Committee on Labor and Human Resources, United States Senate, One Hundred Second Congress, second session, on S. 2135 ... May 19, 1992. (U.S. G.P.O. :, 1992), by United States Senate Committee on Labor and Human Resources (page images at HathiTrust)
FDA medical product approvals : hearing before the Subcommittee on National Economic Growth, Natural Resources, and Regulatory Affairs of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fourth Congress, first session, August 8, 1995. (U.S. G.P.O. :, 1997), by Natural Resources United States. Congress. House. Committee on Government Reform and Oversight. Subcommittee on National Economic Growth (page images at HathiTrust)
Food inspections : FDA should rely more on state agencies : report to the Chairman, Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives (The Office, 1986), by United States General Accounting Office (page images at HathiTrust)
Drug regulation : FDA's computer systems need to be better managed : report to the Chairman, Subcommittee on Intergovernmental Relations and Human Resources, Committee on Government Operations, House of Representatives (The Office, 1986), by United States General Accounting Office (page images at HathiTrust)
AIDS drugs : where are they? : seventy-third report (U.S. G.P.O., 1988), by United States House Committee on Government Operations (page images at HathiTrust)
Generic drug enforcement : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, first session, on H.R. 2454 ... June 26, 1991. (U.S. G.P.O. :, 1991), by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment (page images at HathiTrust)
FDA's drug and device review process : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, second session, February 6, 1992. (U.S. G.P.O. :, 1992), by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations (page images at HathiTrust)
The FDA and the future of American biomedical and food industries : hearing of the Committee on Labor and Human Resources, United States Senate, One Hundred Fourth Congress, first session, on examining activities of the Food and Drug Afministration focusing on the challenges and opportunities facing the pharmaceutical, biotech, medical device, and food industries, and FDA's regulation of these industries, April 5 and 6, 1995. (U.S. G.P.O. :, 1995), by United States Senate Committee on Labor and Human Resources (page images at HathiTrust)
Too early to assess European system's value as model for FDA (The Office ;, 1996), by United States General Accounting Office and United States Senate Committee on Labor and Human Resources (page images at HathiTrust)
Consumer protection at the Food and Drug Administration : hearing before the Ad Hoc Subcommittee on Consumer and Environmental Affairs of the Committee on Governmental Affairs, United States Senate, One Hundred Second Congress, first session, September 27, 1991. (U.S. G.P.O. :, 1994), by United States. Congress. Senate. Committee on Governmental Affairs. Ad Hoc Subcommittee on Consumer and Environmental Affairs (page images at HathiTrust)
Drugs and biologics : hearings before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fourth Congress, first session, May 25, 1995--a consumer's perspective, June 19, 1995--FDA review process. (U.S. G.P.O. :, 1995), by United States House Committee on Commerce, Subcommittee on Oversight and Investigations (page images at HathiTrust)
Food and Drug enforcement standards for medical devices : joint hearing before the Subcommittee on Human Resources and Intergovernmental Relations and the Subcommittee on National Economic Growth, Natural Resources, and Regulatory Affairs of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fourth Congress, first session, September 14, 1995. (U.S. G.P.O. :, 1997), by United States. Congress. House. Committee on Government Reform and Oversight. Subcommittee on Human Resources and Intergovernmental Relations and Natural Resources United States. Congress. House. Committee on Government Reform and Oversight. Subcommittee on National Economic Growth (page images at HathiTrust)
Anesthesia machine failures : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, Ninety-eighth Congress, second session, September 26, 1984. (U.S G.P.O., 1985), by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations (page images at HathiTrust)
FDA's reviews of new drugs : changes needed in process for reviewing and reporting on clinical studies (U.S. G.A.O., 1988), by United States General Accounting Office (page images at HathiTrust)
FDA needs stronger controls over the approval process for new animal drugs (The Office ;, 1992), by United States General Accounting Office and United States. Congress. House of Representatives. Committee on Government Operations. Human Resources and Intergovernmental Relaltions Subcommittee (page images at HathiTrust)
Food and Drug Administration's regulation of dietary supplements : hearing before the Human Resources and Intergovernmental Relations Subcommittee of the Committee on Government Operations, House of Representatives, One Hundred Third Congress, first session, July 20, 1993. (U.S. G.P.O. :, 1994), by United States. Congress. House. Committee on Government Operations. Human Resources and Intergovernmental Relations Subcommittee (page images at HathiTrust)
Food additive approval process followed for aspartame (The Office, 1987), by United States General Accounting Office and Howard M. Metzenbaum (page images at HathiTrust)
FDA review times : statement of Mary R. Hamilton, Director of Program Evaluation in Human Services Areas, Program Evaluation and Methodology Division, before the Subcommittee on Health and Environment, Committee on Commerce, House of Representatives (The Office ;, 1996), by Mary R. Hamilton, United States. Congress. House. Committee on Commerce. Subcommittee on Health and the Environment, and United States General Accounting Office (page images at HathiTrust)
Initial impact of new federal law has been positive (The Office ;, 1995), by United States General Accounting Office (page images at HathiTrust)
Food safety and quality : stronger FDA standards and oversight needed for bottled water : report to the Chairman, Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives (The Office, 1991), by United States General Accounting Office and United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations (page images at HathiTrust)
Domestic food safety : FDA could improve inspection program to make better use of resources : report to the chairman, Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives (The Office, 1989), by United States General Accounting Office (page images at HathiTrust)
Medical devices : early warning of problems is hampered by severe underreporting : report to the chairman, Committee on Governmental Affairs, United States Senate. (U.S. General Accounting Office, 1986), by United States General Accounting Office and United States Senate Committee on Governmental Affairs (page images at HathiTrust)
Medical devices : FDA's forecasts of problem reports and FTEs under H.R. 4640 : report to the Chairman, Subcommittee on Health and the Environment, Committee on Energy and Commerce, House of Representatives (The Office, 1988), by United States General Accounting Office and United States. Congress. Committee on Energy and Commerce. Subcommittee on Health and the Environment (page images at HathiTrust)
Medical devices : underreporting of serious problems with a home apnea monitor : report to the Chairman, Subcommittee on Health and the Environment, Committee on Energy and Commerce, House of Representatives (The Office, 1990), by United States General Accounting Office and United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment (page images at HathiTrust)
FDA's oversight of the 1982 canned salmon recalls : report to the Chairman, Subcommittee on Oversights and Investigations, Committee on Energy and Commerce, House of Representatives (The Office, 1984), by United States General Accounting Office (page images at HathiTrust)
FDA resources : comprehensive assessment of staffing, facilities, and equipment needed : report to congressional requesters (The Office, 1989), by United States General Accounting Office (page images at HathiTrust)
Acceptable risks : politics, policy, and risky technologies (University of Michigan Press, 1997), by C. F. Larry Heimann (page images at HathiTrust)
Federal oversight of shellfish safety needs improvement (The Office, 2001), by United States General Accounting Office (page images at HathiTrust)
Consumer safety and weight-loss supplements (U.S. G.P.O. :, 2002), by Restructuring United States. Congress. Senate. Committee on Governmental Affairs. Subcommittee on Oversight of Government Management (page images at HathiTrust)
Ephedra : who is protecting the American consumers? : hearing before the Oversight of Government Management, Restructuring, and the District of Columbia Subcommittee of the Committee on Governmental Affairs, United States Senate, One Hundred Seventh Congress, second session, October 8, 2002. (U.S. G.P.O. :, 2003), by Restructuring United States. Congress. Senate. Committee on Governmental Affairs. Subcommittee on Oversight of Government Management (page images at HathiTrust)
Nation's premier consumer protection and health agency (U.S. Dept. of Health and Human Services, U.S. Food and Drug Administration, 2003), by United States Food and Drug Administration (page images at HathiTrust)
Oversight of FTC's shared responsibilities : hearing before the Subcommittee on Transportation and Hazardous Materials of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, first session, concerning advertising and labeling issues with the Bureau of Alcohol, Tobacco, and Firearms, the Environmental Protection Agency, and the Food and Drug Administration, November 21, 1991. (U.S. G.P.O. :, 1992), by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Transportation and Hazardous Materials (page images at HathiTrust)
Dietary Supplement Safety Act : how is the Food and Drug Administration doing 10 years later? : hearing before the Oversight of Government Management, the Federal Workforce, and the District of Columbia Subcommittee of the Committee on Governmental Affairs, United States Senate, One Hundred Eighth Congress, second session, June 8, 2004. (U.S. G.P.O. :, 2004), by the Federal Workforce United States. Congress. Senate. Committee on Governmental Affairs. Subcommittee on Oversight of Government Management (page images at HathiTrust)
Food and Drug Administration's drug approval process (U.S. G.P.O. :, 2005), by United States Senate Committee on Health, Education, Labor, and Pensions (page images at HathiTrust)
Building a twenty-first century FDA (U.S. G.P.O. :, 2007), by United States Senate Committee on Health, Education, Labor, and Pensions (page images at HathiTrust)
The adequacy of FDA to assure the safety of the nation's drug supply : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, first session, February 13, March 22, 2007. (U.S. G.P.O. :, 2007), by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations (page images at HathiTrust)
Need for Food and Drug Administration regulation of tobacco (U.S. G.P.O. :, 2007), by United States Senate Committee on Health, Education, Labor, and Pensions (page images at HathiTrust)
The Food and Drug Administration's critical mission and challenges for the future : hearing before the Committee on Oversight and Government Reform, House of Representatives, One Hundred Tenth Congress, first session, May 1, 2007. (U.S. G.P.O. :, 2007), by United States House Committee on Oversight and Government Reform (page images at HathiTrust)
Drug user fees : enhancing patient access and drug safety : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Tenth Congress, first session, on examining enhancing patient access and drug safety relating to prescription drug user fees, including S. 484, March 14, 2007. (U.S. G.P.O. :, 2008), by United States Senate Committee on Health, Education, Labor, and Pensions (page images at HathiTrust)
FDA foreign drug inspection program : a system at risk : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, first session, November 1, 2007. (U.S. G.P.O. :, 2008), by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations (page images at HathiTrust)
FDA's role in the evaluation of Avandia's safety : hearing before the Committee on Oversight and Government Reform, House of Representatives, One Hundred Tenth Congress, first session, June 6, 2007. (U.S. G.P.O. :, 2008), by United States House Committee on Oversight and Government Reform (page images at HathiTrust)
Diminished capacity : can the FDA assure the safety and security of the nation's food supply? : Hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, first session. (U.S. G.P.O. :, 2008), by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations (page images at HathiTrust)
FDA's import enforcement operations. (Dept. of Health and Human Services, Public Health Service, Food and Drug Administration :, 1982), by United States Food and Drug Administration (page images at HathiTrust)
Milestones in U.S. food and drug law history. (U.S. Dept. of Health, and Human Services, Food and Drug Administration, Office of Public Affairs, 1985), by United States. Food and Drug Administration. Office of Public Affairs (page images at HathiTrust)
Food import inspection : hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred First Congress, first session, July 19 and September 28, 1989. (U.S. G.P.O. :, 1989), by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations (page images at HathiTrust)
Nation's foremost consumer protection agency (Dept. of Health and Human Services, Food and Drug Administration, 2000), by United States Food and Drug Administration (page images at HathiTrust)
Nation's foremost consumer protection agency (Dept. of Health and Human Services, Food and Drug Administration, 2001), by United States Food and Drug Administration (page images at HathiTrust)
The FDA Commission : the delegation of authority to state and local authorities. (U.S. Dept. of Human Services, Public Health Service, Food and Drug Administration, 1989), by United States Food and Drug Administration and United States Department of Health and Human Services (page images at HathiTrust)
Public advisory committees. (Dept. of Health, Education, and Welfare, Public Health Service, Food and Drug Administration, Office of Public Affairs., in the 20th century), by United States Food and Drug Administration (page images at HathiTrust)
From test tube to patient : new drug development in the United States. (Dept. of Health & Human Services, Public Health Service, Food and Drug Administration, 1988), by United States Food and Drug Administration (page images at HathiTrust)
From test tube to patient : new drug development in the United States. (Dept. of Health & Human Services, Public Health Service, Food and Drug Administration, 1990), by United States Food and Drug Administration (page images at HathiTrust)
Food safety and quality who does what in the federal government : report to Congressional requesters (The Office, 1990), by United States General Accounting Office (page images at HathiTrust)
How accurate is the FDA's monitoring of supplements like ephedra? : hearing before the Committee on Government Reform, House of Representatives, One Hundred Sixth Congress, first session, May 27, 1999. (U.S. G.P.O. :, 2000), by United State House Committee on Government Reform (page images at HathiTrust)
Extramural research programs supported by the Food and Drug Administration : July 1, 1975 - September 30, 1976 : research grants, contracts, interagency agreements, PL 480 projects (Dept. of Health, Education, and Welfare, Public Health Service, Food and Drug Administration, Office of Science, Extramural Research [Staff], 1977), by United States. Food and Drug Administration. Office of Science. Extramural Research Staff and Thelma J O'Connell (page images at HathiTrust)
FDA's import coverage approaches. (Dept. of Health and Human Services, Public Health Service, Food and Drug Administration :, 1982), by United States Food and Drug Administration (page images at HathiTrust)
The FDA Commission : the delegation of authority to state and local authority. (U.S. Dept. of Human Services, Public Health Service, Food and Drug Administration, 1986), by United States Food and Drug Administration (page images at HathiTrust)
FDA : safeguarding America's health. (Food and Drug Law Institute, 1990), by American Medical Association and Food and Drug Law Institute (U.S.) (page images at HathiTrust)
When a patient speaks-- : patient representatives to FDA advisory committees : a video presented by the U.S. Food and Drug Administration (Office of Special Health Issues :, 1997), by United States. Office of Special Health Issues (page images at HathiTrust)
Clinical trials of medical treatments (Dept. of Health and Human Services, Food and Drug Administration, 2001), by United States Food and Drug Administration (page images at HathiTrust)
Amending the Federal Food, Drug, and Cosmetic Act to require labeling containing information applicable to pediatric patients : report together with additional views (to accompany S. 2394). (U.S. G.P.O., 2002), by United States Senate Committee on Health, Education, Labor, and Pensions (page images at HathiTrust)
FDA services guide : (everything you always wanted to know about services and didn't know where to ask). (U.S. Food and Drug Administration, 1974), by United States Food and Drug Administration (page images at HathiTrust)
U.S.-EU (European Union) mutual recognition agreement on drug inspections (U.S. G.P.O. :, 1998), by United States House Committee on Commerce, Subcommittee on Oversight and Investigations (page images at HathiTrust)
FDA policy on home drug testing kits : hearing before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fifth Congress, first session, February 6, 1997. (U.S. G.P.O. :, 1997), by United States House Committee on Commerce, Subcommittee on Oversight and Investigations (page images at HathiTrust)
FDA's generic drug application policy : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundredth Congress, second session, July 28, 1988. (U.S. G.P.O. :, 1989), by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations (page images at HathiTrust)
FDA regulation of ribavirin : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundredth Congress, first session, May 28, 1987. (U.S. G.P.O. :, 1988), by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations (page images at HathiTrust)
Hard to swallow : FDA enforcement program for imported food : a staff report (U.S. G.P.O. :, 1989), by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations (page images at HathiTrust)
The Bjork-Shiley heart valve, earn as you learn : Shiley Inc.'s breach of the honor system and FDA's failure in medical device regulation : a staff report (U.S. G.P.O. :, 1990), by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations (page images at HathiTrust)
Naked reverse : Secretary Sullivan's rescission of his delegation of investigative authority to the Inspector General : a staff report (U.S. G.P.O. :, 1990), by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations (page images at HathiTrust)
Food and Drug Administration oversight : hearings before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives. (U.S. G.P.O. :, 1991), by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment (page images at HathiTrust)
FDA's generic drug enforcement and approval process : hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, first session, March 7 and June 5, 1991. (U.S. G.P.O. :, 1992), by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations (page images at HathiTrust)
FDA and the medical device industry : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred First Congress, second session, February 26, 1990. (U.S. G.P.O. :, 1990), by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations (page images at HathiTrust)
Sulfites : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, Ninety-ninth Congress, first session, March 27, 1985. (U.S. G.P.O., 1985), by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations (page images at HathiTrust)
Problems with FDA's regulation of the antiarrhythmic drugs Tambocor and Enkaid : hearing before the Human Resources and Intergovernmental Subcommittee of the Committee on Government Operations, House of Representatives, One Hundred Second Congress, first session, April 10, 1991. (U.S. G.P.O. :, 1992), by United States. Congress. House. Committee on Government Operations. Human Resources and Intergovernmental Relations Subcommittee (page images at HathiTrust)
Oversight of the new drug review process and FDA's regulation of Merital : hearing before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-ninth Congress, second session, May 22, 1986. (U.S. G.P.O. :, 1987), by United States. Congress. House. Committee on Government Operations. Intergovernmental Relations and Human Resources Subcommittee (page images at HathiTrust)
The regulation of animal drugs by the Food and Drug Administration : hearings before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-ninth Congress, first session, July 24 and 25, 1985. (U.S. G.P.O., 1986), by United States. Congress. House. Committee on Government Operations. Intergovernmental Relations and Human Resources Subcommittee (page images at HathiTrust)
FDA's regulation of the new drug Suprol : hearing before a subcommittee of the Committee on Government Operations, House of Representatives, One Hundredth Congress, first session, May 27, 1987. (U.S. G.P.O. :, 1988), by United States. Congress. House. Committee on Government Operations. Human Resources and Intergovernmental Relations Subcommittee (page images at HathiTrust)
FDA's regulation of the marketing of unapproved new drugs : the case of E-Ferol vitamin E aqueous solution : hearing before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-eighth Congress, second session, May 4, 1984. (U.S. G.P.O., 1984), by United States. Congress. House. Committee on Government Operations. Intergovernmental Relations and Human Resources Subcommittee (page images at HathiTrust)
FDA proposals to ease restrictions on the use and sale of experimental drugs : hearing before a subcommittee of the Committee on Government Operations, House of Representatives, One hundredth Congress, first session, April 29, 1987. (U.S. G.P.O. :, 1987), by United States. Congress. House. Committee on Government Operations. Human Resources and Intergovernmental Relations Subcommittee (page images at HathiTrust)
Drug efficacy : hearings before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-first Congress, first session. (U.S. Govt. Print. Off, 1970), by United States. Congress. House. Committee on Government Operations. Intergovernmental Relations Subcommittee (page images at HathiTrust)
Regulatory policies of the Food and Drug Administration. Hearing before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-first Congress, second session, June 9, 1970. (U.S. Govt. Print. Off., 1971), by United States. Congress. House. Committee on Government Operations. Intergovernmental Relations Subcommittee (page images at HathiTrust)
FDA consumer protection activities--FDA reorganization. Hearings, Ninety-first Congress, first and second session ... (U.S. Govt. Print. Off., 1970), by United States. Congress. House. Committee on Interstate and Foreign Commerce. Subcommittee on Public Health and Welfare (page images at HathiTrust)
Role of Commissioner of Food and Drugs : hearing before the Committee on Labor and Human Resources, United States Senate, One Hundred Second Congress, first session, on examining the role of the current Commissioner of the Food and Drug Administration, March 6, 1991. (U.S. G.P.O. :, 1992), by United States Senate Committee on Labor and Human Resources (page images at HathiTrust)
FDA Export Reform and Enhancement Act of 1995 : hearing before the Subcommittee on Aging of the Committee on Labor and Human Resources, United States Senate, One Hundred Fourth Congress, first session on S. 593 ... July 13, 1995. (U.S. G.P.O. :, 1995), by United States. Congress. Senate. Committee on Labor and Human Resources. Subcommittee on Aging (page images at HathiTrust)
Punitive damages : tort reform and FDA defenses : hearings before the Committee on the Judiciary, United States Senate, One Hundred Fourth Congress, first session, on S. 671 ... S. 672 ... April 4 and July 26, 1995. (U.S. G.P.O. :, 1996), by United States Senate Committee on the Judiciary (page images at HathiTrust)
Addressing the FDA's performance, efficiency, and use of resources : hearings of the Committee on Labor and Human Resources, United States Senate, One Hundred Fifth Congress, first session ... March 19 and April 11, 1997. (U.S. G.P.O. :, 1997), by United States Senate Committee on Labor and Human Resources (page images at HathiTrust)
Restoring FDA's ability to keep America's families safe : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Tenth Congress, second session, on examining the U.S. Food and Drug Administration, focusing on its ability to ensure the safety of food and the drug supply in the United States, April 24, 2008. (Washington : U.S. G.P.O., 2009., 2009), by United States Senate Committee on Health, Education, Labor, and Pensions (page images at HathiTrust)
FDA's regulation of the new drug Versed : hearings before a subcommittee of the Committee on Government Operations, House of Representatives, One Hundredth Congress, second session, May 5 and 10, 1988. (U.S. G.P.O. :, 1988), by United States. Congress. House. Committee on Government Operations. Human Resources and Intergovernmental Relations Subcommittee (page images at HathiTrust)
To assess the impact of proposed FDA user fees on small business : hearing before the Committee on Small Business, United States Senate, One Hundred First Congress, first session ... June 13, 1989. (U.S. G.P.O. :, 1989), by United States. Congress. Senate. Committee on Small Business (page images at HathiTrust)
RU 486 : the import ban and its effect on medical research : hearing before the Subcommittee on Regulation, Business Opportunities, and Energy of the Committee on Small Business, House of Representatives, One Hundred First Congress, second session, Washington, DC, November 19, 1990. (U.S. G.P.O. :, 1991), by Business Opportunities United States. Congress. House. Committee on Small Business. Subcommittee on Regulation (page images at HathiTrust)
Promotion of drugs and medical devices for unapproved uses : hearing before the Human Resources and Intergovernmental Relations Subcommittee of the Committee on Government Operations, House of Representatives, One Hundred Second Congress, first session, June 11, 1991. (U.S. G.P.O. :, 1992), by United States. Congress. House. Committee on Government Operations. Human Resources and Intergovernmental Relations Subcommittee (page images at HathiTrust)
Filthy food, dubious drugs, and defective devices : the legacy of FDA's antiquated statute : a staff report (U.S. G.P.O. :, 1991), by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations (page images at HathiTrust)
Regulating innovation : FDA's medical device approval process : hearing before the Subcommittee on Investigations and Oversight of the Committee on Science, Space, and Technology, U.S. House of Representatives, One Hundred Third Congress, first session, September 17, 1993. (U.S. G.P.O. :, 1994), by Space United States. Congress. House. Committee on Science (page images at HathiTrust)
Medical technology development and commercialization : hearing before the Subcommittee on Technology of the Committee on Science, U.S. House of Representatives, One Hundred Fourth Congress, first session, November 2, 1995. (U.S. G.P.O. :, 1995), by United States House Subcommittee on Technology (page images at HathiTrust)
Oversight of the Food and Drug Administration's progress in reducing unnecessary paperwork burdens upon small business : hearing before the Subcommittee on Government Programs of the Committee on Small Business, House of Representatives, One Hundred Fourth Congress, second session, Washington, DC, July 24, 1996. (U.S. G.P.O. :, 1997), by United States. Congress. House. Committee on Small Business. Subcommittee on Government Programs (page images at HathiTrust)
Mad cow disease : FDA's management of the feed ban has improved, but oversight weaknesses continue to limit program effectiveness : report to congressional requesters (U.S. Government Accountability Office, 2005), by United States Government Accountability Office (page images at HathiTrust)
Directory of food safety and quality : who does what in the federal government. (U.S. General Accounting Office, 1990), by United States General Accounting Office (page images at HathiTrust)
The Food and drug administration of the United States Department of agriculture. (U.S. G.P.O., 1936), by United States Food and Drug Administration (page images at HathiTrust)
Tobacco legislation and the Food and Drug Administration and smokeless tobacco issues in the proposed settlement : hearing before the Committee on Commerce, Science, and Transportation, United States Senate, One Hundred Fifth Congress, second session, March 17, 1998. (U.S. G.P.O. :, 1999), by United States Senate Committee on Commerce, Science, and Transportation (page images at HathiTrust)
Preclinical and clinical testing by the pharmaceutical industry, 1975- : joint hearings before the Subcommittee on Health of the Committee on Labor and Public Welfare and the Subcommittee on Administrative Practice and Procedure of the Committee on the Judiciary, United States Senate, Ninety-fourth Congress, first session- on examination of the process of drug testing and FDA's role in the regulation and conditions under which such testing is carried out. (U. S. Govt. Print. Off., 1976), by United States Senate Committee on Labor and Public Welfare and United States Senate Committee on the Judiciary (page images at HathiTrust)
The Final report (The Commission, 1980), by Joint Commission on Prescription Drug Use (page images at HathiTrust)
Review of enforcement and certification activities of the Food and Drug Administration, Department of Health, Education, and Welfare, September 1960 : report to the Congress of the United States ([Washington], 1961), by United States General Accounting Office (page images at HathiTrust)
Federal Hazardous Substances Labeling Act : hearing before a subcommittee of the Committee on Interstate and Foreign Commerce, House of Representatives, Eighty-sixth Congress, second session, on H.R. 5260, a bill to regulate the interstate distribution and sale of packages of hazardous substances intended or suitable for household use, March 14, 1960. (U.S. G.P.O., 1960), by United States House Committee on Interstate and Foreign Commerce (page images at HathiTrust)
More effective action needed to control abuse and diversion in methadone treatment programs : Food and Drug Administration, Department of Health, Education, and Welfare, Drug Enforcement Administration, Department of Justice : report to the Congress (U.S. General Accounting Office, 1976), by United States General Accounting Office (page images at HathiTrust)
Need to resolve safety questions on saccharin, Food and Drug Administration, Dept. of Health, Education, and Welfare : report of the Comptroller General of the United States. (U.S. General Accounting Office, 1976), by United States General Accounting Office (page images at HathiTrust)
Federal control of new drug testing is not adequately protecting human test subjects and the public, Food and Drug Administration, Department of Health, Education, and Welfare : report to the Congress (U.S. General Accounting Office, 1976), by United States General Accounting Office (page images at HathiTrust)
Need to establish the safety of color additive FD&C red no. 2, Food and Drug Administration, Department of Health, Education, and Welfare : report of the Comptroller General of the United States. (U.S. General Accounting Office, 1975), by United States General Accounting Office (page images at HathiTrust)
Questions on the safety of the pesticide maleic hydrazide used on potatoes and other crops have not been answered, Environmental Protection Agency, Food and Drug Administration, Department of Health, Education, and Welfare (U.S. General Accounting Office, 1974), by United States General Accounting Office (page images at HathiTrust)
Reinventing the regulation of drugs made from biotechnology (National Performance Review, 1995), by Bill Clinton, Albert Gore, and National Performance Review (U.S.) (page images at HathiTrust)
Reinventing the regulation of cancer drugs : accelerating approval and expanding access (National Performance Review, 1996), by Bill Clinton, Albert Gore, and National Performance Review (U.S.) (page images at HathiTrust)
Medical Device Regulatory Modernization Act of 1997 : report, together with additional views (to accompany H.R. 1710) (including cost estimate of the Congressional Budget Office). (U.S. G.P.O., 1997), by United States. Congress. House. Committee on Commerce (page images at HathiTrust)
Medical Device User Fee and Modernization Act of 2002 : report (to accompany H.R. 3580). (U.S. G.P.O., 2002), by United States House. Committee on Energy and Commerce (page images at HathiTrust)
Complementary and alternative medicine in government-funded health programs : hearing before the Committee on Government Reform House of Representatives, One Hundred Sixth Congress, first session, February 24, 1999. (U.S. G.P.O. :, 1999), by United State House Committee on Government Reform (page images at HathiTrust)
FDA regulation of blood safety : notification, recall, and enforcement practices : hearing before the Subcommittee on Human Resources of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fifth Congress, first session, June 5, 1997. (U.S. G.P.O. :, 1997), by United States. Congress. House. Committee on Government Reform and Oversight. Subcommittee on Human Resources (page images at HathiTrust)
Clinical trial subjects : adequate FDA protections? : hearing before the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fifth Congress, second session, April 22, 1998. (U.S. G.P.O. :, 1998), by United States. Congress. House. Committee on Government Reform and Oversight (page images at HathiTrust)
Council on Competitiveness and FDA plans to alter the drug approval process at FDA : hearing before the Human Resources and Intergovernmental Relations Subcommittee of the Committee on Government Operations, House of Representatives, One Hundred Second Congress, second session, March 19, 1992. (U.S. G.P.O. :, 1993), by United States. Congress. House. Committee on Government Operations. Human Resources and Intergovernmental Relations Subcommittee (page images at HathiTrust)
The regulation of new drugs by the Food and Drug Administration : the new drug review process : hearings before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-seventh Congress, second session, August 3 and 4, 1982. (U.S. G.P.O. :, 1982), by United States. Congress. House. Committee on Government Operations. Intergovernmental Relations and Human Resources Subcommittee (page images at HathiTrust)
Use of advisory committees by the Food and Drug Administration : hearings before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-third Congress, second session. (U.S. Govt. Print. Off, 1974), by United States. Congress. House. Committee on Government Operations. Intergovernmental Relations Subcommittee and United States. Congress. House. Committee on Government Operations. Intergovernmental Relations and Human Resources Subcommittee (page images at HathiTrust)
FDA's regulation of Zomax : hearings before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-eighth Congress, first session, April 26 and 27, 1983. (U.S. G.P.O. :, 1983), by United States. Congress. House. Committee on Government Operations. Intergovernmental Relations and Human Resources Subcommittee (page images at HathiTrust)
FDA regulation of medical devices, including the status of breast implants : joint hearing before the Subcommittee on Human Resources and Intergovernmental Relations and the Subcommittee on National Economic Growth, Natural Resources, and Regulatory Affairs of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fourth Congress, first session, August 1, 1995. (U.S. G.P.O. :, 1996), by United States. Congress. House. Committee on Government Reform and Oversight. Subcommittee on Human Resources and Intergovernmental Relations and Natural Resources United States. Congress. House. Committee on Government Reform and Oversight. Subcommittee on National Economic Growth (page images at HathiTrust)
Mercury in medicine, are we taking unnecessary risks? (U.S. G.P.O. :, 2001), by United State House Committee on Government Reform (page images at HathiTrust)
Off label drug use and FDA review of supplemental drug applications (U.S. G.P.O. :, 1997), by United States. Congress. House. Committee on Government Reform and Oversight. Subcommittee on Human Resources and Intergovernmental Relations (page images at HathiTrust)
Oversight of NIH and FDA : bioethics and the adequacy of informed consent : hearing before the Subcommittee on Human Resources of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fifth Congress, first session, May 8, 1997. (U.S. G.P.O. :, 1997), by United States. Congress. House. Committee on Government Reform and Oversight. Subcommittee on Human Resources (page images at HathiTrust)
Patient access to alternative treatments : beyond the FDA : hearings before the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fifth Congress, second session, February 4 and 12, 1998. (U.S. G.P.O. :, 1998), by United States. Congress. House. Committee on Government Reform and Oversight (page images at HathiTrust)
Proposed remedies for relief in the Drug Patent Term Restoration Review Procedure Act of 1999 (U.S. G.P.O. :, 2000), by United States Senate Committee on the Judiciary (page images at HathiTrust)
Food and Drug Administration practice and procedure, 1975 : joint hearings before the Subcommittee on Health of the Committee on Labor and Public Welfare and the Subcommittee on Administrative Practice and Procedure of the Committee on the Judiciary, United States Senate, Ninety-fourth Congress, first session ... January 28, 1975, the Dalkon Shield, January 29, 1975, Bureau of Veterinary Medicine and Bureau of Foods. (U.S. Govt. Print. Off. :, 1975), by United States. Congress. Senate. Committee on Labor and Public Welfare. Subcommittee on Health and United States. Congress. Senate. Committee on the Judiciary. Subcommittee on Administrative Practice and Procedure (page images at HathiTrust)
Preclinical and clinical testing by the pharmaceutical industry, 1975[-1976] : joint hearings before the Subcommittee on Health of the Committee on Labor and Public Welfare and the Subcommittee on Administrative Practice and Procedure of the Committee on the Judiciary, United States Senate, Ninety-fourth Congress, second session, on examination of the process of drug testing and FDA's role in the regulation and conditions under which such testing is carried out. (U.S. Govt. Print. Off, 1975), by United States. Congress. Senate. Committee on Labor and Public Welfare. Subcommittee on Health and United States. Congress. Senate. Committee on the Judiciary. Subcommittee on Administrative Practice and Procedure (page images at HathiTrust)
Medical devices : hearing before the Committee on Labor and Human Resources, United States Senate, One Hundred First Congress, second session, on examining proposed legislation to revise and strengthen the Food and Drug Administration's regulation of medical devices, July 25, 1990. (U.S. G.P.O. :, 1991), by United States Senate Committee on Labor and Human Resources (page images at HathiTrust)
Administration's position on the tobacco settlement : hearings of the Committee on Labor and Human Resources, United States Senate, One Hundred Fifth Congress, first session ... September 25, 1997. (U.S. G.P.O. :, 1997), by United States Senate Committee on Labor and Human Resources (page images at HathiTrust)
Ensuring drug safety : where do we go from here? : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, first session, on examining the Food and Drug Administration's process of ensuring drug safety, March 3, 2005. (U.S. G.P.O. :, 2005), by United States Senate Committee on Health, Education, Labor, and Pensions (page images at HathiTrust)
Patient safety and anticancer drugs, 1983 : hearing before the Committee on labor and Human Resources, United States Senate, Ninety-eighth Congress, first session on examination of the effects of anticancer drugs in the treatment of cancer patients, June 23, 1983. (U.S. G.P.O. :, 1984), by United States Senate Committee on Labor and Human Resources (page images at HathiTrust)
Human food safety and the regulation of animal drugs : twenty-seventh report (U.S. G.P.O., 1986), by United States House Committee on Government Operations (page images at HathiTrust)
FDA's approach to reviewing over-the-counter drugs is reasonable, but progress is slow : report to the Congress (U.S. General Accounting Office, 1982), by United States General Accounting Office (page images at HathiTrust)
Imported foods : opportunities to improve FDA's inspection program : report to the Chairman, Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives (The Office, 1989), by United States General Accounting Office and United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations (page images at HathiTrust)
Medical device recalls : an overview and analysis 1983-88 : report to the Chairman, Subcommittee on Health and the Environment, Committee on Energy and Commerce, House of Representatives (The Office, 1989), by United States General Accounting Office and United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment (page images at HathiTrust)
Continuing concerns over imported pharmaceuticals : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, first session, June 7, 2001. (U.S. G.P.O. :, 2001), by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations (page images at HathiTrust)
Processed fruits and vegetables: potentially adulterated products need to be better controlled, sanitation in some plants needs improvement; report to the Congress [on the] Agricultural Marketing Service ... [and the] Food and Drug Administration ... ([Washington, 1973), by United States General Accounting Office (page images at HathiTrust)
Discussion draft of the Food and Drug Administration Globalization Act legislation device and cosmetic safety provisions : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, second session, May 14, 2008. (U.S. G.P.O. :, 2008), by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health (page images at HathiTrust)
FDA's foreign drug inspection program : weaknesses place Americans at risk : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, second session, April 22, 2008. (U.S. G.P.O. :, 2008), by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations (page images at HathiTrust)
Chemicals in food products : hearings before the House Select Committee to Investigate the Use of Chemicals in Food Products, House of Representatives, eighty-first Congress, second session, created pursuant to H. Res. 323. Washington: September 14, 15, 19, and 21, 1950; Chicago: November 15, 16, and 17, 1950; Washington: November 28, 29, 30, December 1, 5, 6, 7, 8, 11, 12, 13, 14, and 15, 1950. (U.S. GPO, 1951), by United States. Congress. House. Select Committee to Investigate the Use of Chemicals in Food Products and American Public Health Association. Committee on Chemicals Introduced in Foods (page images at HathiTrust)
Food and Drug Administration Procedures for the Selection of Laboratory Sites : hearings before the United States House Committee on Government Operations, Subcommittee on Intergovernmental Relations, Ninetieth Congress, first session, on June 28, 1967. (U.S. G.P.O., 1967), by United States. Congress. House. Committee on Government Operations. Intergovernmental Relations Subcommittee (page images at HathiTrust)
Preclinical and clinical testing by the pharmaceutical industry, 1976 : joint hearings before the Subcommittee on Health of the Committee on Labor and Public Welfare and the Subcommittee on Administrative Practice and Procedure of the Committee on the Judiciary, United States Senate, Ninety-fourth Congress, second session, on examination of the process of drug testing and FDA's role in the regulation and conditions under which such testing is carried out. (U.S. Govt. Print. Off, 1975), by United States. Congress. Senate. Committee on Labor and Public Welfare. Subcommittee on Health and United States. Congress. Senate. Committee on the Judiciary. Subcommittee on Administrative Practice and Procedure (page images at HathiTrust)
The FDA Commission : the delegation of authority to state and local officials. (U.S. Department of Health, Education, and Welfare, Public Health Service, Consumer Protection and Environmental Health Service, Food and Drug Administration, 1969), by United States Food and Drug Administration (page images at HathiTrust)
Protecting consumers of foods, drugs, & cosmetics (U.S. Department of Health, Education, and Welfare, Food and Drug Administration, Division of Administrative Management, 1961), by United States Food and Drug Administration (page images at HathiTrust)
How the FDA works for you. ([Food and Drug Administration, Dept. of Health, Education, and Welfare], 1968), by United States Food and Drug Administration (page images at HathiTrust)
Food and Drug Administration-- what it is, and does. (U.S. Dept. of Health, Education, and Welfare, Food and Drug Administration, 1958), by United States Food and Drug Administration (page images at HathiTrust)
Drug safety : an update from the Food and Drug Administration : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Eleventh Congress, second session, March 10, 2010. (Washington, DC : For sale by the Superintendent of Documents, U.S. Government Printing Office., 2012), by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health (page images at HathiTrust)
The role and performance of FDA in ensuring food safety : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Eleventh Congress, second session, May 6, 2010. (Washington, DC : For sale by the Superintendent of Documents, U.S. Government Printing Office., 2012), by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations (page images at HathiTrust)
Impact of medical device regulation on jobs and patients : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Twelfth Congress, first session, February 17, 2011. (U.S. G.P.O. :, 2011), by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health (page images at HathiTrust)
Food and Drug Administration's program for regulating imported products needs improving, Department of Health, Education, and Welfare, Department of the Treasury : report to the Congress (U.S. General Accounting Office], 1977), by United States General Accounting Office (page images at HathiTrust)
Tools for compliance for the medical device and in vitrol diagnostic product industries. (Dept. of Health, Education, and Welfare, Public health Service, Food and Drug Administration, Bureau of Medical Devices and Diagnostic Products , 1976), by United States. Bureau of Medical Devices and Diagnostic Products (page images at HathiTrust)
Basic facts of the grain sanitation program (University of Illinois, College of Agriculture, Extension Service in Agriculture and Home Economics], 1955), by L. F. Stice (page images at HathiTrust)
Enhancing safeguards would strengthen the nation's blood supply (The Office ;, 1997), by Bernice Steinhardt, United States. Congress. House. Committee on Government Reform and Oversight. Subcommittee on Human Resources, and United States General Accounting Office (page images at HathiTrust)
Labor-Federal Security appropriations for 1951 (U.S. G.P.O., 1950), by United States. Congress. Senate. Committee on Appropriations (page images at HathiTrust)
Grain-sanitation program of the Food and Drug Administration. Hearings ... Eighty-third Congress, first session, on implementation of grain-sanitation program of the Food and Drug Administration with respect to insect infestation of wheat, March 10 and 11, 1953. (U.S. Govt. Print. Off., 1953), by United States. Congress. Senate. Committee on Agriculture and Forestry (page images at HathiTrust)
The Food and Drug Administration : Federal Security Agency : enforcement of the Food, Drug, and Cosmetic Act, Tea Act, Caustic Poison Act, Import Milk Act, Filled Milk Act. (U.S. G.P.O., 1941), by United States Food and Drug Administration (page images at HathiTrust)
FDA oversight : medical devices : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, Ninety-seventh Congress, second session, July 16, 1982. (U.S. G.P.O., 1982), by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations (page images at HathiTrust)
Regulation of the food additive aspartame : Food and Drug Administration, Department of Health, Education, and Welfare : report of the Comptroller General of the United States. (U.S. General Accounting Office, 1976), by United States General Accounting Office (page images at HathiTrust)
Assessment of the Commissioner's report of October 1975. (DHEW, 1976), by Education United States. Dept. of Health (page images at HathiTrust)
Food, drug, cosmetic, and device enforcement amendments : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, first session, on H.R. 2597, a bill to amend the Federal Food, Drug, and Cosmetic Act to enhance the enforcement authority of the Food and Drug Administration, July 17, 1991. (U.S. G.P.O. :, 1991), by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment (page images at HathiTrust)
Bottled water regulation : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, first session, April 10, 1991. (U.S. G.P.O. :, 1991), by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations (page images at HathiTrust)
Enforcement of the food, drug, and cosmetic act, tea act, import milk act, caustic poison act, filled milk act. (U.S. Govt. print. off., 1941), by United States Food and Drug Administration (page images at HathiTrust)
Diminished capacity : can the FDA assure the safety and security of the nation's food supply? : hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, first session. (U.S. G.P.O. :, 2008), by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations (page images at HathiTrust)
Commission on the Federal Drug Approval Process : final report (U.S. G.P.O., 1982), by United States. Commission on the Federal Drug Approval Process, United States. Congress. House. Committee on Science and Technology. Subcommittee on Investigations and Oversight, and Agriculture Research United States. Congress. House. Committee on Science and Technology. Subcommittee on Natural Resources (page images at HathiTrust)
An Act to Amend the Federal Food, Drug, and Cosmetic Act to Revitalize the Food and Drug Administration, and for Other Purposes. (U.S. G.P.O. :, 1990), by United States (page images at HathiTrust)
The protection of human life (Food and Drug Administration, U.S. Dept. of Healthe, Education, and Welfare, 1967), by United States Food and Drug Administration (page images at HathiTrust)
FDA compliance policy guides manual. (U. S. Food and Drug Administration ; Springfield, Va. :, 1981), by United States Food and Drug Administration and United States. Food and Drug Administration. Executive Director of Regional Operations (page images at HathiTrust)
Background material for the development of the Food and Drug Administration's recommendations on thyroid-blocking with potassium iodide (U.S. Dept. of Health and Human Services, Public Health Service, Food and Drug Administration, Bureau of Radiological Health ;, 1981), by Jerome A Halperin, United States. Food and Drug Administration. Bureau of Drugs, and United States. Bureau of Radiological Health (page images at HathiTrust)
Reforming the food safety system (U.S. G.P.O. :, 2011), by United States Senate Committee on Health, Education, Labor, and Pensions (page images at HathiTrust)
A consumer guide to FDA. (Dept. of Health, Education, and Wefare, Public Health Service, Food and Drug Administration, 1978), by United States Food and Drug Administration (page images at HathiTrust)
Drug safety : most drugs withdrawn in recent years had greater health risks for women (The Office, 2001), by United States General Accounting Office (page images at HathiTrust)
Food and Drug Administration and the 95th Congress : January 1, 1977--December 31, 1978. (Dept. of Health, Education, and Welfare, Public Health Service, Food and Drug Administration, Office of Legislative Affairs, 1979), by United States. Food and Drug Administration. Office of Legislative Affairs (page images at HathiTrust)
Food allergies : separating fact from "hype" (United States Government Printing Office, 1986), by Richard C. Thompson, United States Department of Health and Human Services, and United States. Food and Drug Administration. Office of Public Affairs (page images at HathiTrust)
Measure-act-measure : food warehouses : Project Idea 11--pilot study, January 72 (Food and Drug Administration, U.S. Department of Health, Education, and Welfare, 1972), by Carmin Soviero, Theodore L Rotto, and Dale Madden (page images at HathiTrust)
Medical device reprocessing (Washington, D.C. : The Office, [2000], 2000), by United States General Accounting Office (page images at HathiTrust)
Preclinical and clinical testing by the pharmaceutical industry, 1975 : joint Hearings before the Subcommittee on Health of the Committee on Labor and Public Welfare, and the Subcommittee on Administrative Practice and Procedure of the Committee on the Judiciary, United States Senate, Ninety-fourth Congress, first session- (U.S. Govt. Print. Off., 1975), by United States. Congress. Senate. Committee on Labor and Public Welfare. Subcommittee on Health and United States. Congress. Senate. Committee on the Judiciary. Subcommittee on Administrative Practice and Procedure (page images at HathiTrust)
FDA compliance policy guides manual. (U. S. Department of Health, Education, and Welfare, Food and Drug Administration, 1973), by United States. Food and Drug Administration. Executive Director of Regional Operations (page images at HathiTrust)

Find more by United States Food and Drug Administration at your library, or elsewhere.

The Online Books Page

United States Food and Drug Administration

(United States. Food and Drug Administration)